CANNAPHARMARX, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
CANNAPHARMARX, INC. (CPMD) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $1.51 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-10.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2025-04-10
- CANNAPHARMARX, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2021-03-31 was -$348.33K.
- CANNAPHARMARX, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2020-03-31 was -$24.36K.
- CANNAPHARMARX, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $1.51K.
- CANNAPHARMARX, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$1.67K.
- CANNAPHARMARX, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2021 was -$580.57K, a 322.44% decline from fiscal 2020.
- CANNAPHARMARX, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2020 was $261.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|
| 2024-12-31 | $1.51K 10-K · filed 2025-04-10 | ||
| 2024-09-30 | $6.35K 10-Q · filed 2024-11-14 | ||
| 2023-12-31 | -$1.67K 10-K · filed 2025-04-10 | ||
| 2023-09-30 | -$2.32K 10-Q · filed 2024-11-14 | ||
| 2022-09-30 | -$20.27K 10-Q · filed 2023-11-17 | ||
| 2021-12-31 | -$580.57K 10-K · filed 2022-04-15 | ||
| 2021-09-30 | -$482.00K 10-Q · filed 2021-11-15 | ||
| 2021-03-31 | -$348.33K 10-Q · filed 2021-05-17 | ||
| 2020-12-31 | $261.00K 10-K · filed 2022-04-15 | ||
| 2020-09-30 | $189.63K 10-Q · filed 2021-11-15 | ||
| 2020-03-31 | -$24.36K 10-Q · filed 2021-05-17 | ||
| 2019-12-31 | -$575.26K 10-K · filed 2021-04-14 | ||
| 2018-12-31 | $464.12K 10-K · filed 2020-05-27 |